| Execution period | Financial Year 2026-27 |
|---|
BSE filing, BSE: 544409. Summary written from the filing by ALFA Finder's alert engine.
Astonea Labs Ltd: key numbers
- Share price
- ₹323.00
- Market cap
- ₹339.5 Cr
- Revenue (annual)
- ₹147.6 Cr
- Net profit (annual)
- ₹4.52 Cr
- P/E (TTM)
- 75.2×Sector 46.1×
- Promoter holding
- 72.44%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Astonea Labs Ltd
All →Astonea Labs Merger & Restructuring Worth ₹0.05 Cr
Astonea Labs has incorporated a new subsidiary, 'Longevity Science Private Limited.' The company will invest Rs. 0.05 Crore to hold 51% equity share capital.
- Value
- ₹0.05 Cr
Astonea Labs Other Announcement
Astonea Labs Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI LODR Regulations, 2015, for the quarter ended September 30, 2026.
Astonea Labs H2 FY25 Results: Net Profit ₹3.2 Cr, Up 52.4% QoQ
Astonea Labs Ltd reported revenue from operations of ₹50.2 Cr and net profit of ₹3.2 Cr for H2 FY25.
- Key figure
- Net profit ₹3.2 Cr
Astonea Labs Results Correction
Astonea Labs has resubmitted its standalone financial results for FY25 in PDF format following a BSE query regarding discrepancies in its initial XBRL-only submission.
Astonea Labs Promoter Buying: ₹0.43 Cr
Promoter Ashish Gulati acquired 14,000 shares of Astonea Labs Ltd from the open market between September 15 and 16, 2026.
- Value
- ₹0.43 Cr
- Promoter stake change
- +0.04%
Astonea Labs Promoter Buying
Promoter Ashish Gulati acquired 14,000 equity shares of Astonea Labs Ltd via open market transactions between September 15 and 16, 2026.
- Promoter stake change
- +0.13%
Other other announcement announcements
All →Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals reported no deviation in utilising the Rs 95 Crore raised via a preferential warrant issue for the quarter ended September 30, 2026. Audit Committee reviewed the statement and the Board took it on record.
- Value
- ₹95.00 Cr
NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.